Cargando…

mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer

PURPOSE: S100A8 is a member of the S100 protein family containing 2EF-hand calcium-binding motifs. S100 proteins are involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. Altered expression of this protein is associated with various diseases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Yun-Sok, Kim, Min-Ju, Yoon, Hyung-Yoon, Kang, Ho-Won, Kim, Yong-June, Yun, Seok-Joong, Lee, Sang-Cheol, Kim, Wun-Jae
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855462/ https://www.ncbi.nlm.nih.gov/pubmed/20414404 http://dx.doi.org/10.4111/kju.2010.51.1.15

Ejemplares similares

FAM70B as a Novel Prognostic Marker for Cancer Progression and Cancer-Specific Death in Muscle-Invasive Bladder Cancer
por: Kang, Ho-Won, et al.
Publicado: (2012)

Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2010)

Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis
por: Jeong, Pildu, et al.
Publicado: (2015)

GSTT1 as a Prognosticator for Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Forkhead box O-class 1 and Forkhead box G1 as Prognostic Markers for Bladder Cancer
por: Kim, Tae-Hwan, et al.
Publicado: (2009)

Granular Cell Tumor of the Urinary Bladder
por: Kang, Ho-Won, et al.
Publicado: (2010)

Comparison of Metabolic Risk Factors in Urolithiasis Patients according to Family History
por: Park, Cheol, et al.
Publicado: (2010)

Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder Cancer
por: Kim, Young-Won, et al.
Publicado: (2015)

Novel Combination Markers for Predicting Survival in Patients with Muscle Invasive Bladder Cancer: USP18 and DGCR2
por: Kim, Ye-Hwan, et al.
Publicado: (2014)

Pyrosequencing Analysis of APC Methylation Level in Human Prostate Tissues: A Molecular Marker for Prostate Cancer
por: Yoon, Hyung-Yoon, et al.
Publicado: (2013)

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
por: Kim, Wun-Jae, et al.
Publicado: (2010)

GSTM1 Tissue Genotype as a Recurrence Predictor in Non-muscle Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2011)

Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
por: Kim, Yong-June, et al.
Publicado: (2016)

Phosphaturia as a Promising Predictor of Recurrent Stone Formation in Patients with Urolithiasis
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
por: Kim, Sung Min, et al.
Publicado: (2013)

Identification of C16orf74 as a Marker of Progression in Primary Non-Muscle Invasive Bladder Cancer
por: Kim, Won Tae, et al.
Publicado: (2010)

Epigenetic Markers for Bladder Cancer in Urine
por: Kim, Wun-Jae, et al.
Publicado: (2007)

Tumor heterogeneity in muscle-invasive bladder cancer
por: Kang, Ho Won, et al.
Publicado: (2020)

Alpha-Methylacyl-Coenzyme A Racemase-Expressing Urachal Adenocarcinoma of the Abdominal Wall
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Chronological Trends in Clinical and Urinary Metabolic Features over 20 Years in Korean Urolithiasis Patients
por: Kang, Ho Won, et al.
Publicado: (2017)

DNA Methylation of GSTP1 in Human Prostate Tissues: Pyrosequencing Analysis
por: Yoon, Hyung-Yoon, et al.
Publicado: (2012)

The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease
por: Kim, Young-Won, et al.
Publicado: (2015)

Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target
por: Yun, Seok Joong, et al.
Publicado: (2013)

Expectant Management of Ureter Stones: Outcome and Clinical Factors of Spontaneous Passage in a Single Institution's Experience
por: Tchey, Dong-Un, et al.
Publicado: (2011)

Nutritional status assessed by the Controlling Nutritional Status (CONUT) score as a predictor of recurrence of urolithiasis
por: Lee, Hee Youn, et al.
Publicado: (2021)

Impact of Transobturator Tape Treatment on Overactive Bladder Symptoms, Particularly Nocturia, in Patients With Mixed Urinary Incontinence
por: Lee, Sang Keun, et al.
Publicado: (2014)

Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma
por: Ha, Yun-Sok, et al.
Publicado: (2014)

Diagnostic and Prognostic Markers in Bladder Cancer
por: Ku, Ja Hyeon, et al.
Publicado: (2016)

Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer
por: Lee, Il-Seok, et al.
Publicado: (2017)

Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray
por: Lee, Myung-Shin, et al.
Publicado: (2015)

How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?
por: Yun, Seok Joong, et al.
Publicado: (2016)

Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer
por: Kim, Won Tae, et al.
Publicado: (2018)

Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression
por: Piao, Xuan-Mei, et al.
Publicado: (2021)

A high basal metabolic rate is an independent predictor of stone recurrence in obese patients
por: Kang, Ho Won, et al.
Publicado: (2021)

Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer
por: Yan, Chunri, et al.
Publicado: (2015)

Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer
por: Shim, Ui Jae, et al.
Publicado: (2013)

A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone
por: Kang, Ho Won, et al.
Publicado: (2020)

The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma
por: Kang, Ho Won, et al.
Publicado: (2020)

Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
por: Jin, Xing, et al.
Publicado: (2014)

A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guérin Therapy
por: Kim, Seon-Kyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nfo9u22n2ttgjmtcb2eem29tbb